NovoCure Limited
(NVCR)
undefined
undefined%
At close: undefined
33.30
-0.06%
After-hours Dec 13, 2024, 07:55 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
Revenue | 509.34M | 537.84M | 535.03M | 494.37M | 351.32M | 248.07M | 177.03M | 82.89M | 33.09M | 15.49M | 10.36M |
Cost of Revenue | 128.28M | 114.87M | 114.88M | 106.50M | 88.61M | 80.05M | 55.61M | 46.28M | 20.61M | 10.04M | 7.01M |
Gross Profit | 381.06M | 422.97M | 420.15M | 387.87M | 262.71M | 168.02M | 121.42M | 36.61M | 12.48M | 5.45M | 3.35M |
Operating Income | -232.87M | -89.52M | -44.33M | 21.25M | -914.00K | -33.67M | -39.33M | -115.32M | -104.00M | -80.16M | -64.46M |
Interest Income | 46.04M | 10.96M | 791.00K | 1.79M | 4.40M | 2.65M | 1.12M | 659.00K | 84.00K | 143.00K | 267.00K |
Pretax Income | -191.74M | -81.85M | -52.08M | 18.10M | -8.82M | -45.94M | -48.50M | -121.46M | -107.15M | -80.30M | -77.02M |
Net Income | -207.04M | -92.53M | -58.35M | 19.81M | -7.23M | -63.56M | -61.66M | -131.84M | -111.58M | -80.68M | -77.37M |
Selling & General & Admin | 390.87M | 306.41M | 263.18M | 225.45M | 184.62M | 151.12M | 122.64M | 110.46M | 72.72M | 45.23M | 33.01M |
Research & Development | 223.06M | 206.09M | 201.30M | 132.01M | 79.00M | 50.57M | 38.10M | 41.47M | 43.75M | 40.38M | 34.80M |
Other Expenses | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | 613.93M | 512.50M | 464.49M | 357.46M | 263.63M | 201.69M | 160.75M | 151.92M | 116.47M | 85.61M | 67.81M |
Interest Expense | 3.32M | 3.33M | 3.44M | 13.15M | 13.72M | 13.49M | 10.26M | 5.94M | 2.37M | 41.00K | 7.16M |
Selling & Marketing Expenses | 226.81M | 173.66M | 137.06M | 118.02M | 96.67M | 77.66M | 63.53M | 59.45M | 38.86M | 21.18M | 16.41M |
Cost & Expenses | 742.21M | 627.36M | 579.36M | 463.96M | 352.23M | 281.74M | 216.35M | 198.21M | 137.08M | 95.65M | 74.82M |
Income Tax | 15.30M | 10.69M | 6.28M | -1.71M | -1.59M | 17.62M | 13.16M | 10.38M | 4.43M | 382.00K | 353.00K |
Shares Outstanding (Basic) | 106.39M | 104.66M | 103.43M | 100.93M | 97.24M | 91.83M | 88.55M | 85.56M | 30.40M | 72.14M | 72.14M |
Shares Outstanding (Diluted) | 106.39M | 104.66M | 103.43M | 108.88M | 97.24M | 91.83M | 88.55M | 85.56M | 30.40M | 72.14M | 72.14M |
EPS (Basic) | -1.95 | -0.88 | -0.56 | 0.20 | -0.07 | -0.69 | -0.7 | -1.54 | -3.67 | -1.12 | -1.07 |
EPS (Diluted) | -1.95 | -0.88 | -0.56 | 0.18 | -0.07 | -0.69 | -0.7 | -1.54 | -3.67 | -1.12 | -1.07 |
EBITDA | -175.87M | -63.11M | -38.38M | 45.30M | 14.21M | -23.45M | -29.13M | -108.89M | -101.11M | -78.19M | -63.13M |
Depreciation & Amortization | 10.97M | 10.62M | 10.25M | 9.15M | 8.39M | 9.01M | 7.68M | 5.65M | 3.15M | 1.96M | 1.22M |